QNCX

QNCX

USD

Quince Therapeutics Inc. Common Stock

$1.600+0.040 (2.564%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.560

Máximo

$1.620

Mínimo

$1.555

Volumen

0.11M

Fundamentos de la Empresa

Capitalización de Mercado

85.9M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.27M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $0.72Actual $1.600Máximo $2.45

Noticias Relacionadas

BusinessWire

Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting

Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced the poster presentation of

Ver más
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting
Analyst Upgrades

D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $4 Price Target

D. Boral Capital analyst Jason Kolbert maintains Quince Therapeutics with a Buy and maintains $4 price target.

Ver más
D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $4 Price Target
BusinessWire

Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study

Quince Therapeutics, Inc.

Ver más
Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.